病态肥胖患者全膝关节置换术后单独使用阿司匹林与肺栓塞风险升高相关:索赔数据库分析
基于全国行政索赔数据库,20,097例初次全膝关节置换术后仅使用阿司匹林预防静脉血栓栓塞的患者按体重指数(BMI)分为<30、30至39.9和≥40三组。多变量分析显示,与BMI<30组相比,BMI≥40组术后90天内肺栓塞发生率更高(比值比2.74),但该效应在180天时消失;BMI 30至39.9组深静脉血栓或肺栓塞发生率无差异。
要点
- 病态肥胖(BMI≥40)患者全膝关节置换术后仅用阿司匹林预防静脉血栓栓塞,90天内肺栓塞发生率高于BMI<30组,比值比2.74。
- 肥胖(BMI 30至39.9)患者与BMI<30组相比,术后90天或180天深静脉血栓或肺栓塞发生率无差异。
- BMI≥40组行清创、抗生素和假体保留手术的调整比值比高于BMI<30组,其他次要结局无差异。
核心结论
- 初次全膝关节置换术后以阿司匹林作为标准化单药预防静脉血栓栓塞时,病态肥胖患者90天内肺栓塞发生率升高,而肥胖患者深静脉血栓或肺栓塞发生率无差异。
研究设计与样本
- 使用全国行政索赔数据库,纳入20,097例初次全膝关节置换术后3天内仅有阿司匹林处方、无其他预防药物的患者,按体重指数(BMI)分为<30、30至39.9和≥40三组,评估术后90天和180天深静脉血栓及肺栓塞发生率。
主要发现
- BMI<30、30至39.9和≥40组分别有4,277例(21%)、10,663例(53%)和5,157例(26%)。
- 多变量分析中,与BMI<30组相比,BMI 30至39.9组术后90天或180天内深静脉血栓或肺栓塞发生率无差异。
- 与BMI<30组相比,BMI≥40组术后90天内肺栓塞发生率更高(比值比2.74),该效应在180天时消失。
- 与BMI<30组相比,BMI≥40组清创、抗生素和假体保留手术的调整比值比更高;除此之外,次要结局发生率按BMI无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aspirin is the most common drug used for venous thromboembolism (VTE) prophylaxis after total knee arthroplasty (TKA). Morbid obesity is a potential risk factor for VTE, prompting some to use stronger anticoagulants. However, there are no established guidelines for VTE prevention in obese or morbidly obese patients undergoing primary TKA. METHODS: Using a national administrative claims database, patients who underwent primary TKA were divided into the following three cohorts based on body mass index (BMI): < 30, 30 to 39.9, or ≥ 40. Each patient had a prescription claim for aspirin, but no other prophylaxis agents within 3 days after the index procedure. We assessed deep vein thrombosis (DVT) and pulmonary embolism (PE) incidence at 90 and 180 days postoperatively. Secondary outcomes included wound dehiscence; hematoma; periprosthetic joint infection; and debridement, antibiotics, and implant retention or explantation procedures. We included 20,097 patients, of whom 4,277 (21%), 10,663 (53%), and 5,157 (26%) had a BMI < 30, 30 to 39.9, and ≥ 40, respectively. RESULTS: In the multivariable analysis, there was no difference in the incidence of DVT or PE within 90 or 180 days after surgery for the BMI 30 to 39.9 compared to the BMI < 30 cohort. However, the incidence of PE within 90 days after surgery was higher in the BMI ≥ 40 cohort (odds ratio: 2.74), an effect that disappeared by 180 days. There was a higher adjusted odds of debridement, antibiotics, and implant retention procedures in the BMI ≥ 40 compared to the BMI < 30 cohort; otherwise, the incidence of secondary outcomes did not differ by BMI. CONCLUSIONS: When aspirin was used as a standardized monotherapy for VTE prophylaxis following primary TKA, there was an increased 90-day incidence of PE in morbidly obese patients but no difference in DVT or PE incidence in obese patients.
引用
- Alqazzaz A, Zhuang T, Smith WE, et al. Higher Pulmonary Embolism Risk in Morbidly Obese Patients on Aspirin Monotherapy after Total Knee Arthroplasty: A Claims Database Analysis. J Arthroplasty. 2025. PMID: 40132696. doi:10.1016/j.arth.2025.03.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。